FDA Approves First Biosimilar Insulin Product
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.